About this source
- Kind
- Research
- Design
- Human clinical trial, RCT
- Population
- 3,808 adults, 55 to 85, early-stage symptomatic Alzheimer's disease, amyloid-confirmed
- Sample size
- 3808
- Primary or secondary
- primary
- Peer review
- peer reviewed
- Retraction status
- None known
- Date checked
- 14 August 2026
Limitations
Negative primary-endpoint result; sponsor-funded.
Cited in
Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.